Oxford Biomedica plc (OXB) Ordinary 50p

- Add to watchlist
- Create an alert
- This stock can be held in a




Share news, reports & tips
-
RBC Capital Markets raises target price on OXB
26 August 2025 08:41
(Sharecast News) - Analysts at RBC Capital Markets hiked their target price on gene and cell therapy firm OXB from 800p to 930p on Tuesday following its recent oversubscribed £60m equity funding and revenue...
-
Oxford Biomedica raises £60m to bolster US capacity
15 August 2025 07:36
(Sharecast News) - Oxford Biomedica has raised £60m via a share placing and subcription to expand its US operations, the gene and cell therapy company announced on Friday.
-
Oxford Biomedica agrees new four-year, $125m loan facility
1 August 2025 10:52
(Sharecast News) - Oxford Biomedica announced on Friday that it has agreed a new four-year loan facility of up to $125m with Oaktree Capital Management, refinancing its existing debt and providing additional...
-
Oxford Biomedica flags sharp rise in first-half revenue
28 July 2025 11:41
(Sharecast News) - Oxford Biomedica reported a sharp rise in first-half revenue and strong commercial momentum on Monday, as it reiterated its full-year guidance and pointed to growing demand across its cell...
-
Oxford Biomedica acquires last 10pc stake in US subsidiary
23 June 2025 11:20
(Sharecast News) - Oxford Biomedica said on Monday it has acquired the remaining 10% stake in its US subsidiary, OXB US, from Q32 Bio, bringing its ownership of the business to 100% as previously planned.
-
Oxford Biomedica reports first-half revenue growth
23 September 2024 11:16
(Sharecast News) - Oxford Biomedica, a prominent gene and cell therapy company, reported significant revenue growth alongside strategic advancements in its interim results on Monday.
-
Oxford Biomedica still expecting small loss after solid first half
8 August 2024 12:38
(Sharecast News) - Cell and gene therapy contract development and manufacturing organisation Oxford Biomedica reported a strong first-half trading performance in an update on Thursday, with revenue expected...
-
Oxford Biomedica appoints new finance chief
17 July 2024 09:51
(Sharecast News) - Cell and gene therapy contract development and manufacturing organisation (CDMO) Oxford Biomedica announced the appointment of Lucinda 'Lucy' Crabtree as its new chief financial...
-
Oxford Biomedica confident as it moves away from vaccine era
29 April 2024 08:09
(Sharecast News) - Cell and gene therapy contract development and manufacturing organisation (CDMO) Oxford Biomedica reported stability in its core business on Monday, with a small increase in full-year core...
-
Oxford Biomedica shares rise on post-acquisition guidance
5 March 2024 16:22
(Sharecast News) - Shares in cell and gene therapy specialist Oxford Biomedica were jumping on Tuesday afternoon, after the company updated the market on its medium-term financial guidance.
-
Director dealings: TUI, Oxford Biomedica board members linked to buys
27 September 2023 11:24
(Sharecast News) - TUI was among those on the list of director buys on Wednesday after its chief executive officer purchased almost 50,000 shares.
-
Liberum cuts target price for Oxford Biomedica, saying it still lacks sufficient scale
28 November 2022 11:43
(Sharecast News) - Analysts at Liberum cut their target price for shares Oxford Biomedica arguing that the company's pan-vector offering had yet to reach sufficient scale in order to deliver sustainable...
Company announcements Announcements
-
Total Voting Rights
1 September 2025 07:00
Oxford Biomedica
-
PDMR Dealings
22 August 2025 15:36
Oxford Biomedica
-
Holding(s) in Company
21 August 2025 10:24
Oxford Biomedica
-
Admission of Shares and Total Voting Rights
20 August 2025 07:00
Oxford Biomedica
-
PDMR Dealings
15 August 2025 13:45
Oxford Biomedica
-
Results of Placing
15 August 2025 07:05
Oxford Biomedica
-
Proposed Placing of New Ordinary Shares
14 August 2025 17:02
Oxford Biomedica
-
OXB Secures New Loan Facility with Oaktree
1 August 2025 07:00
Oxford Biomedica
-
Total Voting Rights
1 August 2025 07:00
Oxford Biomedica
-
Half Year Trading Update
28 July 2025 07:00
Oxford Biomedica
-
Director Declaration
2 July 2025 07:00
Oxford Biomedica
-
Block listing Interim Review
1 July 2025 07:00
Oxford Biomedica
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2025. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.